Selective changes of retroelement expression in human prostate cancer

Carcinogenesis

Volumn 32, Issue 10, 2011, Pages 1484-1492

  Goering, Wolfgang ^a   Ribarska, Teodora ^a   Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CHROMOSOME 22Q; CONTROLLED STUDY; DNA METHYLATION; DNA RESPONSIVE ELEMENT; GENE CONSTRUCT; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN GENOME; HUMAN TISSUE; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PYROSEQUENCING; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA, NEOPLASM; ENDOGENOUS RETROVIRUSES; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; LUCIFERASES; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; PROVIRUSES; RETROELEMENTS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 80053158287     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr181     Document Type: Article

References (53)

1. Schulz,W.A. et al. (2006) Methylation of endogenous human retroelements in health and disease. Curr. Top. Microbiol. Immunol., 310, 211-250.
2. Goodier,J.L. et al. (2008) Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell, 135, 23-35.
3. Kurth,R. et al. (2010) Beneficial and detrimental effects of human endogenous retroviruses. Int. J. Cancer, 126, 306-314.
4. Schumann,G.G. et al. (2010) Unique functions of repetitive transcriptomes. Int. Rev. Cell Mol. Biol., 285, 115-188.
5. Santourlidis,S. et al. (1999) High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate, 39, 166-174.
6. Florl,A.R. et al. (2004) Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br. J. Cancer, 91, 985-994.
7. Yegnasubramanian,S. et al. (2008) DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res., 68, 8954-8967.
8. Herbst,H. et al. (1998) Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS, 106, 216-220.
9. Roelofs,H. et al. (1998) Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications. Am. J. Pathol., 153, 1277-1282.
10. Wang-Johanning,F. et al. (2003) Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer, 98, 187-197.
11. Ishida,T. et al. (2008) Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun., 8, 15.
12. Tomlins,S.A. et al. (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature, 448, 595-599.
13. Hermans,K.G. et al. (2008) Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer. Cancer Res., 68, 7541-7549.
14. Kumar-Sinha,C. et al. (2008) Recurrent gene fusions in prostate cancer. Nat. Rev. Cancer., 8, 497-511.
15. Wlazlinski,A. et al. (2007) Downregulation of severa fibulin genes in prostate cancer. Prostate, 67, 1770-1780.
16. Pfaffl,M.W. et al. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, e45.
17. Ribarska,T. et al. (2010) Epigenetic inactivation of the placentally imprinted tumor suppressor gene TFPI2 in prostate carcinoma. Cancer Genomics Proteomics, 7, 51-60.
18. Steinhoff,C. et al. (2003) Transcriptional regulation of the human LINE-1 retrotransposon L1.2B. Mol. Genet. Genomics., 270, 394-402.
19. Cronauer,M.V. et al. (2004) Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines. Oncogene, 23, 3541-3549.
20. Belancio,V.P. et al. (2010) Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res., 38, 3909-3922.
21. Jurka,J. et al. (2005) Repbase Update, a database of eukaryotic repetitive elements. Cytogenet. Genome Res., 110, 462-467.
22. Penzkofer,T. et al. (2005) L1Base: from functional annotation to prediction of active LINE-1 elements. Nucleic Acids Res., 33, D498-D500.
23. Fujita,P.A. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res., 39, D876-D882.
24. Dehm,S.M. et al. (2008) Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res., 68, 5469-5477.
25. Schulz,W.A. et al. (2010) Changes in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation. BMC Cancer, 10, 505.
26. Bannert,N. et al. (2004) Retroelements and the human genome: new perspectives on an old relation. Proc. Natl Acad. Sci. USA., 101 (suppl. 2), 14572-14579.
27. Stauffer,Y. et al. (2004) Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun., 4, 2.
28. Flockerzi,A. et al. (2008) Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics, 9, 354.
29. Fuchs,N.V. et al. (2011) Expression of the human endogenous retrovirus (HERV) group HML-2/HERV-K does not depend on canonical promoter elements but is regulated by transcription factors Sp1 and Sp3. J. Virol., 85, 3436-3448.
30. Lin,C. et al. (2009) Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell, 139, 1069-1083.
31. Mani,R.S. et al. (2009) Induced chromosomal proximity and gene fusions in prostate cancer. Science, 326, 1230.
32. Norris,J.D. et al. (2009) The homeodomain protein HOXB13 regulates the cellular response to androgens. Mol. Cell., 36, 405-416.
33. Jung,C. et al. (2004) HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res., 64, 3046-3051.
34. Yu,J. et al. (2010) An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell, 17, 443-454.
35. Denne,M. et al. (2007) Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J. Virol., 81, 5607-5616.
36. Armbruester,V. et al. (2004) Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J. Virol., 78, 10310-10319.
37. Armbruester,V. et al. (2002) A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin Cancer Res., 8, 1800-1807.
38. Kaufmann,S. et al. (2010) Human endogenous retrovirus protein Rec interacts with the testicular zinc-finger protein and androgen receptor. J. Gen. Virol., 91, 1494-1502.
39. Kim,H.S. et al. (2006) Human Endogenous Retrovirus (HERV)-R family in primates: chromosomal location, gene expression, and evolution. Gene, 370, 34-42.
40. Yi,J.M. et al. (2007) Molecular phylogenetic analysis of the human endogenous retrovirus E (HERV-E) family in human tissues and human cancers. Genes Genet. Syst., 82, 89-98.
41. Piskareva,O. et al. (2011) The human L1 element: a potential biomarker in cancer prognosis, current status and future directions. Curr. Mol. Med., 11, 286-303.
42. Rangwala,S.H. (2009) Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol., 10, R100.
43. Macia,A. et al. (2011) Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol. Cell. Biol., 31, 300-316.
44. Beck,C.R. et al. (2010) LINE-1 retrotransposition activity in human genomes. Cell, 141, 1159-1170.
45. Huang,C.R. et al. (2010) Mobile interspersed repeats are major structural variants in the human genome. Cell, 141, 1171-1182.
46. Iskow,R.C. et al. (2010) Natural mutagenesis of human genomes by endogenous retrotransposons. Cell, 141, 1253-1261.
47. Schulz,W.A. et al. (2006) L1 retrotransposons in human cancers. J. Biomed. Biotechnol., 2006, 83672.
48. Goodier,J.L. et al. (2010) Discrete subcellular partitioning of human retrotransposon RNAs despite a common mechanism of genome insertion. Hum. Mol. Genet., 19, 1712-1725.
49. White,R.J. et al. (2008) Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat. Rev. Cancer., 8, 911-914.
50. Li,T.H. et al. (2001) Differential stress induction of individual Alu loci: implications for transcription and retrotransposition. Gene, 276, 135-141.
51. Rodriguez,J. et al. (2008) Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells. Nucleic Acids Res., 36, 770-784.
52. Xie,H. et al. (2009) High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res., 37, 4331-4340.
53. Rand,K.N. et al. (2010) Sensitive measurement of unmethylated repeat DNA sequences by end-specific PCR. Biotechniques, 49, xiii-xvii.